Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) thro... Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants). Show more
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners...
2025 Grant Application Process Now Open for Up to $300,000 in Funding Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2025 Annual Research Award Program to support...
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners...
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners...
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and...
Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 6.55 | 2.93261696888 | 223.35 | 231.86 | 213.175 | 820841 | 222.75778865 | CS |
4 | 17.35 | 8.16278522701 | 212.55 | 231.86 | 204.925 | 974562 | 216.42446678 | CS |
12 | -1.32 | -0.570884871551 | 231.22 | 262.87 | 204.925 | 776416 | 226.66295164 | CS |
26 | -39.84 | -14.769778305 | 269.74 | 272.17 | 196.09 | 821019 | 234.42830569 | CS |
52 | 23.4 | 11.3317191283 | 206.5 | 335.4 | 196.09 | 830772 | 254.66476252 | CS |
156 | -455.65 | -66.4648822114 | 685.55 | 691.96 | 172.05 | 892461 | 293.98143652 | CS |
260 | -39.7 | -14.7255192878 | 269.6 | 737.452 | 127.88 | 835812 | 330.84169686 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.